Viewing Study NCT00982657


Ignite Creation Date: 2025-12-24 @ 6:32 PM
Ignite Modification Date: 2025-12-28 @ 11:09 AM
Study NCT ID: NCT00982657
Status: TERMINATED
Last Update Posted: 2015-11-20
First Post: 2009-09-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Trial Of CVX-060, An Anti-Angiogenic COVX-Body, In Combination With Sunitinib In Patients With Advanced Renal Cell Carcinoma
Sponsor: Pfizer
Organization: